Skip to main content

Table 1 Baseline demographic and clinical characteristics in individuals with and without glycemic impairment at baseline

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD, Median (IQR), or n (%) Glycemic Impairment (n = 73) Normal Glycemia (n = 55) p-value
Sex (male) 29 (40) 18 (33) 0.002
Age (years) 56 ± 9 57 ± 7 0.897
Current Smokers 3 (4) 3 (5) 0.386
Physical Activity (MET-minutes/week) 1313 (585, 2940) 1365 (683, 2333) 0.942
Systolic Blood Pressure (mm Hg) 127 ± 15 117 ± 16 <0.001
Diastolic Blood Pressure (mm Hg) 75 ± 12 69 ± 9 0.002
Total Cholesterol (mg/dL) 191 ± 33 194 ± 31 0.683
LDL-c (mg/dL) 116 ± 31 117 ± 27 0.731
HDL-c (md/dL) 47 ± 13 53 ± 15 0.016
Triglycerides (mg/dL) 146 ± 72 115 ± 39 0.006
Fasting Blood Glucose (mg/dL) 105 ± 21 87 ± 6 <0.001
Insulin (μIU/mL) 15 ± 11 10 ± 5 0.001
HOMA-IR (μIU/mL*mmol/L) 4.1 ± 3.4 2.2 ± 1.1 <0.001
Body Mass Index (kg/m2) 26.9 ± 5.1 24.7 ± 3.6 0.006
Waist Circumference (cm) 98 ± 13 91 ± 11 0.003
  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation